Established in 2017 by the American Cancer Society with support from an unrestricted, educational grant from AstraZeneca, the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) is a coalition of public, private, and voluntary organizations dedicated to reducing the incidence of and mortality from lung cancer in the United States. Through coordinated leadership, strategic planning, advocacy, collaboration, and action, the ACS NLCRT will more rapidly advance lung cancer care and control through efforts to increase public and provider education, risk reduction, and early detection, quality assurance, equitable access to care, effective health policy, and optimal diagnosis and treatment for individuals with lung cancer.

ACS NLCRT members know that they amplify the impact they can have in their efforts to control lung cancer by working through the ACS NLCRT with other members on critical and complex issues. Members can be part of initiatives, research, and published works that ultimately benefit individuals with lung cancer and their families.

The ACS NLCRT is an organization of organizations, and we invite you to join. Review the organizational membership information below and complete the Membership Application form to submit your application for membership. Please be sure to complete the entire form.